Larry L. Wood, President, CEO at PROCEPT BioRobotics Corp (PRCT), bought 23,900 shares at $20.85 ($498K) on 2026-08-07, disclosed to the SEC on 2026-08-10.
CEO Larry Wood purchased 23,900 shares for $498k at $20.85, marking the largest purchase of his career and signaling confidence in the company's valuation. The trade comes as the stock has rallied 18% over the last five days despite a 43% year-to-date decline.
PRCT is trading at $21.72, up 18.08% over the last 5 days and 3.92% over the last 30 days, but remains down 24.36% over the last 90 days and 43.47% over the last year. The stock is currently 49.15% below its 52-week high of $42.71.
Q2 2026 earnings on August 11, 2026, will be critical following a 32% revenue surge in HYDROS systems. Additionally, the company lowered full-year procedure guidance due to legacy AquaBeam softness, creating a potential inflection point for the stock.
The stock faces significant headwinds from class action lawsuits alleging undisclosed discounting practices inflated sales, and a short interest of 12.74% of the float. Analysts have recently cut price targets to the low-to-mid $20s citing competition risk and legal overhang.
Something here stands out, but not much.
| Filing → |
| EW | SELL | 2024-11-05 | $1.6M | — | Filing → |
| EW | SELL | 2023-12-13 | $1.2M | — | Filing → |
| EW | SELL | 2023-11-13 | $1.1M | — | Filing → |